![Michael Alfieri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Alfieri
Finanzdirektor/CFO bei
ALDEYRA THERAPEUTICS, INC.
Vermögen: 9 225 $ am 30.09.2026
Profil
Michael Alfieri is Chief Financial & Accounting Officer, Head-Finance at Aldeyra Therapeutics, Inc. since 2024.
Former roles include Controller & Executive Director-Finance at Anika Therapeutics, Inc. from 2010 to 2014, Vice President-Finance at Radius Health, Inc. from 2017 to 2018, VP-Finance, Chief Financial & Accounting Officer at Genocea Biosciences, Inc. from 2018 to 2019, and Controller at Merrimack Pharmaceuticals, Inc. from 2014 to 2017.
Education includes undergraduate and graduate degrees from Bentley University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.04.2026 | 7’500 ( 0.01% ) | 9 225 $ | 30.09.2026 |
Aktive Positionen von Michael Alfieri
| Unternehmen | Position | Beginn |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Finanzdirektor/CFO | 31.08.2024 |
Ehemalige bekannte Positionen von Michael Alfieri
| Unternehmen | Position | Ende |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01.05.2018 |
| MERRIMACK PHARMACEUTICALS | Comptroller/Controller/Auditor | 01.01.2017 |
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.07.2014 |
| GENOCEA BIOSCIENCES, INC. | Finanzdirektor/CFO | 05.03.2019 |
Ausbildung von Michael Alfieri
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
